ALL PUBLICATIONS

Autonomy after specific or polyvalent rehabilitation in the post stroke population. An analysis of the french inpatient database

Published on : 18/04/2013
Latest update on : 24/10/2012

Conference, symposium

Hospitalisation of diabetic children in France based on data from the Entred-Enfant 2007 survey. Main results

As in many other countries, the incidence of diabetes is increasing in France, where it has virtually doubled over the past twenty years, rising from 8 cases per 100,000 children in 1988 to an estimated 15 cases per 100,000 in 2007. In individuals under the age of 20 years, between 2006 and 2009, the mean annual increase in the prevalence of treated diabetes varied between 2.4% and 3.9% according to age group and gender. The Entred-Enfant study was initiated following the conclusions of the expert assessment of epidemiological monitoring of paediatric diabetes, which InVS (Institut de veille sanitaire - French Institute for Public Health Surveillance) entrusted to INSERM (Institut national de la santé et de la recherche médicale French national health and medical research institute) in...

Published on : 06/03/2013
Latest update on : 15/03/2013

Report and summary

Hospitalisation of diabetic children in France based on data from the Entred-Enfant 2007 survey

As in many other countries, the incidence of diabetes is increasing in France, where it has virtually doubled over the past twenty years, rising from 8 cases per 100,000 children in 1988 to an estimated 15 cases per 100,000 in 2007. In individuals under the age of 20 years, between 2006 and 2009, the mean annual increase in the prevalence of treated diabetes varied between 2.4% and 3.9% according to age group and gender. The Entred-Enfant study was initiated following the conclusions of the expert assessment of epidemiological monitoring of paediatric diabetes, which InVS (Institut de veille sanitaire - French Institute for Public Health Surveillance) entrusted to INSERM (Institut national de la santé et de la recherche médicale – French national health and medical research institute)...

Published on : 06/03/2013

Characteristics of French people using organised colorectal cancer screening. Analysis of the 2010 French Health, Healthcare and Insurance Survey

Objective. To analyse relationships between socio-demographic characteristics, healthcare access, and behaviour with regard to participation in organised colorectal cancer (CRC) screening. Methods. We analysed a subset of 2,276 individuals from a cross-sectional population-based survey of French households in 2010. The outcome was participation in CRC screening using multiple logistic regression. The studied variables included socio-demographic characteristics, healthcare access-related variables, and health or perceived health. Results. Age, living in a pilot district for CRC screening, and having a private additional insurance were associated with participation in CRC screening for both genders. In men, other characteristics were associated: not having 100% coverage for medical fees for a...

Published on : 01/01/2013
Latest update on : 10/05/2013

Scientific manuscript

Cancer incidence and survival in adolescents and young adults in france, 2000-2008

This study aimed to describe cancer incidence (2000-2008) and survival (2000-2004) in France in adolescents and young adults (AYA). All cases of cancer diagnosed in 15-24 years, recorded by all French population-based registries (14% of the French population), over the 2000-2008 period, were included. Incidence change over time was described with the conventional annual percentage change (cAPC). The survival of cases diagnosed (2000-2004) was estimated using Kaplan-Meier method. A total of 1022 in adolescents and 1396 in young adults were diagnosed. Overall incidence rates were 219.4/10(6) in 15-19 year olds and 293.1/10(6) in 20-24 year olds. The most frequently diagnosed cancers in male AYA were malignant gonadal germ-cell tumors and Hodgkin's disease, and were melanoma, thyroid carcinoma...

Published on : 01/01/2013
Latest update on : 25/04/2013

Scientific manuscript

Unbiased estimates of long-term net survival of hematological malignancy patients detailed by major subtypes in France

Long-term population-based survival data detailed by cancer subtype are important to measure the overall outcomes of malignancy managements. We provide net survival estimates at 1, 3, 5 and 10-year postdiagnosis on 37,549 hematological malignancy (HM) patients whose ages were >15 years, diagnosed between 1989 and 2004 and actively followed until 2008 by French population-based cancer registries. These are, to our knowledge, the first unbiased estimates of 10-year net survival in HMs detailed by subtypes. HMs were classified according to the International Classification of Diseases-Oncology 3. Net survival was estimated with the unbiased Pohar-Perme method. The results are reported by sex and age classes. The changes of these indicators by periods of diagnosis were tabulated and the trends of...

Published on : 01/01/2013
Latest update on : 26/03/2013

Scientific manuscript

Author's reply to: estimating net survival in population-based cancer studies

Published on : 01/01/2013
Latest update on : 22/03/2013

Scientific manuscript

National cancer incidence is estimated using the incidence/mortality ratio in countries with local incidence data: is this estimation correct ?

BACKGROUND: In countries with local cancer registration, the national cancer incidence is usually estimated by multiplying the national mortality by the incidence/mortality (I/M) ratio from pooled registries. This study aims at validating this I/M estimation in France, by a comparison with estimation obtained using the ratio of incidence over hospital discharge (I/HD) or the ratio of incidence over health insurance data (long-duration diseases, I/LDD). METHODS: This comparison was performed for 22 cancer sites over the period 2004-2006. In France, a longitudinal I/M approach was developed relying on incidence and mortality trend analyses; here, the corresponding estimations of national incidence were extracted for 2004-2006. The I/HD and I/LDD estimations were performed using a common cross...

Published on : 01/01/2013
Latest update on : 28/01/2013

Scientific manuscript

Cancer incidence estimation at a district level without a national registry: a validation study for 24 cancer sites using French health insurance and registry data

Background: District-level cancer incidence estimation is an important issue in countries without a national cancer registry. This study aims to both evaluate the validity of district-level estimations in France for 24 cancer sites, using health insurance data (ALD demands -Affection de Longue Durée) and to provide estimations when considered valid. Incidence is estimated at a district-level by applying the ratio between the number of first ALD demands and incident cases (ALD/I ratio), observed in those districts with cancer registries, to the number of first ALD demands available in all districts. These district-level estimations are valid if the ratio does not vary greatly across the districts or if variations remain moderate compared with variations in incidence rates. Methods: Validation...

Published on : 01/01/2013
Latest update on : 24/12/2012

Scientific manuscript

Cancer net survival on registry data: use of the new unbiased Pohar-Perme estimator and magnitude of the bias with the classical methods

Net survival, the survival which might occur if cancer was the only cause of death, is a major epidemiological indicator required for international or temporal comparisons. Recent findings have shown that all classical methods used for routine estimation of net survival from cancer-registry data, sometimes called "relative-survival methods," provide biased estimates. Meanwhile, an unbiased estimator, the Pohar-Perme estimator (PPE), was recently proposed. Using real data, we investigated the magnitude of the errors made by four "relative-survival" methods (Ederer I, Hakulinen, Ederer II and a univariable regression model) vs. PPE as reference and examined the influence of time of follow-up, cancer prognosis, and age on the errors made. The data concerned seven cancer sites (2,51,316 cases)...

Published on : 01/01/2013
Latest update on : 22/10/2012

Scientific manuscript